Reassessing Recipient Mortality Under the New Heart Allocation System: An Updated UNOS Registry Analysis.


Journal

JACC. Heart failure
ISSN: 2213-1787
Titre abrégé: JACC Heart Fail
Pays: United States
ID NLM: 101598241

Informations de publication

Date de publication:
07 2020
Historique:
received: 17 12 2019
revised: 18 02 2020
accepted: 06 03 2020
pubmed: 18 5 2020
medline: 28 4 2021
entrez: 18 5 2020
Statut: ppublish

Résumé

An early report of recipient heart transplantation outcomes under the new U.S. heart allocation system introduced in late 2018 found a lower post-transplant survival rate compared with that of the prior system. The aim of this study was to examine recipient survival under the new system by using an updated dataset. The 2015 to 2019 United Network for Organ Sharing registry was queried for adult heart transplant recipients, stratified according to whether the subjects were listed and underwent transplant before or after October 18, 2018, when the new allocation system was implemented. The association between allocation system and recipient mortality was analyzed by using the Kaplan-Meier method and multivariable Cox proportional hazards regression. A total of 7,119 recipients met inclusion criteria: 6,004 (84%) and 1,115 (16%) listed and undergoing transplant in the old and new allocation systems, respectively. This registry update included 576 new-system recipients, more than double the amount previously analyzed. Recipients from the new system were more likely to be bridged to transplant with temporary mechanical circulatory support devices instead of durable left ventricular assist devices and had longer graft ischemic times. After adjustment, the new system was not associated with poorer survival on Kaplan-Meier survival analysis (log-rank test; p = 0.075) or multivariable Cox proportional hazards modeling (adjusted hazard ratio: 1.18; 95% confidence interval: 0.90 to 1.55). The short-term survival of recipients listed and receiving a transplant under the old and new allocation systems seems to be comparable. The modification to the allocation system has resulted in several changes to the clinical profiles of patients undergoing transplants that must be closely monitored in the coming years.

Sections du résumé

BACKGROUND
An early report of recipient heart transplantation outcomes under the new U.S. heart allocation system introduced in late 2018 found a lower post-transplant survival rate compared with that of the prior system.
OBJECTIVES
The aim of this study was to examine recipient survival under the new system by using an updated dataset.
METHODS
The 2015 to 2019 United Network for Organ Sharing registry was queried for adult heart transplant recipients, stratified according to whether the subjects were listed and underwent transplant before or after October 18, 2018, when the new allocation system was implemented. The association between allocation system and recipient mortality was analyzed by using the Kaplan-Meier method and multivariable Cox proportional hazards regression.
RESULTS
A total of 7,119 recipients met inclusion criteria: 6,004 (84%) and 1,115 (16%) listed and undergoing transplant in the old and new allocation systems, respectively. This registry update included 576 new-system recipients, more than double the amount previously analyzed. Recipients from the new system were more likely to be bridged to transplant with temporary mechanical circulatory support devices instead of durable left ventricular assist devices and had longer graft ischemic times. After adjustment, the new system was not associated with poorer survival on Kaplan-Meier survival analysis (log-rank test; p = 0.075) or multivariable Cox proportional hazards modeling (adjusted hazard ratio: 1.18; 95% confidence interval: 0.90 to 1.55).
CONCLUSIONS
The short-term survival of recipients listed and receiving a transplant under the old and new allocation systems seems to be comparable. The modification to the allocation system has resulted in several changes to the clinical profiles of patients undergoing transplants that must be closely monitored in the coming years.

Identifiants

pubmed: 32417413
pii: S2213-1779(20)30206-7
doi: 10.1016/j.jchf.2020.03.010
pmc: PMC7335324
mid: NIHMS1586002
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

548-556

Subventions

Organisme : NCI NIH HHS
ID : T32 CA093245
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL069749
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Références

J Heart Lung Transplant. 2016 May;35(5):547-9
pubmed: 27197770
J Heart Lung Transplant. 2019 Aug;38(8):858-869
pubmed: 31072751
JACC Heart Fail. 2014 Apr;2(2):166-77
pubmed: 24720925
J Am Coll Cardiol. 2012 Jul 3;60(1):52-3
pubmed: 22541832
J Heart Lung Transplant. 2020 Jan;39(1):1-4
pubmed: 31810767
Am J Transplant. 2015 Jan;15(1):44-54
pubmed: 25534445
Am J Transplant. 2015 Jan;15(1):55-63
pubmed: 25534656
J Heart Lung Transplant. 2011 Jun;30(6):644-51
pubmed: 21470878
J Thorac Cardiovasc Surg. 2016 Dec;152(6):1484-1486
pubmed: 27692950
J Heart Lung Transplant. 2017 Oct;36(10):1037-1046
pubmed: 28779893
J Am Coll Cardiol. 2012 Jul 3;60(1):36-43
pubmed: 22541833
Am J Transplant. 2014 Aug;14(8):1723-30
pubmed: 25040084
J Heart Lung Transplant. 2020 Jan 30;:
pubmed: 32037250
Lancet. 2015 Jun 27;385(9987):2577-84
pubmed: 25888086
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1607-1618.e6
pubmed: 29361299
J Heart Lung Transplant. 2019 Aug;38(8):870-871
pubmed: 31178380
J Am Coll Cardiol. 2014 Apr 1;63(12):1179-1181
pubmed: 24486268

Auteurs

Oliver K Jawitz (OK)

Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina. Electronic address: oliver.jawitz@duke.edu.

Marat Fudim (M)

Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.

Vignesh Raman (V)

Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.

Benjamin S Bryner (BS)

Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.

Adam D DeVore (AD)

Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.

Robert J Mentz (RJ)

Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.

Carmelo Milano (C)

Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.

Chetan B Patel (CB)

Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.

Jacob N Schroder (JN)

Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.

Joseph G Rogers (JG)

Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina; Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH